Contrasting Texxon (NASDAQ:NPT) & Transcat (NASDAQ:TRNS)

Texxon (NASDAQ:NPT) and Transcat (NASDAQ:TRNS) are both small-cap industrials companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations for Texxon and Transcat, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Texxon	1	0	0	0	1.00
Transcat	1	2	0	0	1.67

Transcat has a consensus target price of $95.00, suggesting a potential upside of 2.70%. Given Transcat’s stronger consensus rating and higher probable upside, analysts plainly believe Transcat is more favorable than Texxon.

Valuation and Earnings

This table compares Texxon and Transcat”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Texxon	$614.57 million	0.13	-$930,000.00	N/A	N/A
Transcat	$331.88 million	2.61	$5.38 million	$0.37	250.00

Transcat has lower revenue, but higher earnings than Texxon.

Institutional & Insider Ownership

98.3% of Transcat shares are owned by institutional investors. 1.0% of Texxon shares are owned by insiders. Comparatively, 1.8% of Transcat shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Texxon and Transcat’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Texxon	N/A	N/A	N/A
Transcat	0.99%	5.56%	3.44%

Summary

Transcat beats Texxon on 9 of the 10 factors compared between the two stocks.

About Texxon

Texxon Holding Limited is a provider of supply chain management services in the plastics and chemical industries principally in East China. Texxon Holding Limited is based in Shanghai, China.

About Transcat

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers’ assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers’ test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.